BioSpace News Archive

Senhwa Biosciences, Inc. announced that their first patient has been successfully dosed in Taiwan Phase II Study of Silmitasertib in Hospitalized Adults with COVID-19.

Ikena Oncology, Inc., a targeted oncology company forging new territory in patient-directed cancer treatment, announced financial results for the quarter ended September 30, 2023, and provided a corporate update.

March Biosciences and Cancer Focus Fund, LP announced that Cancer Focus Fund is investing $4.8 million in funding and providing clinical support for March Bio’s upcoming Phase 2 clinical trial of MB-105 for the treatment of relapsed T-cell leukemias and lymphomas.

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update.

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial results for the third quarter ended September 30, 2023.

ZyVersa Therapeutics, Inc. announces publication of an article in the peer-reviewed Biomedical Journal demonstrating that inhibiting NLRP3 inflammasomes in an IBD animal model attenuates intestinal inflammation and tissue damage, leading to significant improvements in IBD symptoms, and restoration of normal intestinal microbial flora.

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it will be delaying the release of its third quarter 2023 results and investor conference call, previously scheduled for today, Thursday, November 9, 2023.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the third quarter ended September 30, 2023, and provided a business update.

Verrica Pharmaceuticals Inc. today announced financial results for the third quarter ended September 30, 2023.

Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2024 operating results on Tuesday, November 14, 2023, before the open of the U.S. financial markets.